Current Knowledge on Skin Cancer Prevention in Liver Transplant Recipients.

Abstract

The improved survival of liver transplant recipients (LTRs) has been accompanied by a concomitant rise in long-term liver transplantation complications, including skin cancer. A recent study found that the prevalence of skin cancer among LTRs is 13.5%, a rate equivalent to that observed among kidney transplant recipients. Given the morbidity associated with skin cancer in LTRs, an individualized, multidisciplinary approach to skin cancer prevention that incorporates patient education, encourages consistent use of primary prevention methods, and ensures routine dermatologic screening should be universally adopted in this population. Chemopreventative measures should be considered in LTRs with a high skin cancer burden. Furthermore, additional studies should be performed in order to systematize these recommendations.

• Authors: G Alden Holmes, Joseph Soo, Sharon E Jacob
• Journal: Progress in transplantation (Aliso Viejo, Calif.) (Prog Transplant) Vol. 28 Issue 4 Pg. 376-379 (12 2018) ISSN: 1526-9248 [Print] United States
• PMID: 30249159 (Publication Type: Journal Article)

Chemical References

• Immunosuppressive Agents

Topics

• Adult
• Aged
• Aged, 80 and over
• Female
• Health Knowledge, Attitudes, Practice
• Humans
• Immunosuppressive Agents (adverse effects)
• Kidney Transplantation (adverse effects)
• Liver Transplantation (adverse effects)
• Male
• Middle Aged
• Prevalence
• Risk Factors
• Skin Neoplasms (etiology, prevention & control)
• Transplant Recipients (psychology)